Article
Emerging AI and Biomarker–Driven Precision Medicine in Autoimmune Rheumatic Diseases: From Diagnostics to Therapeutic Decision-Making
2025-10-13
Abstract excerpt
Autoimmune rheumatic diseases (AIRD) are heterogeneous, relapsing–remitting disorders in which early diagnosis, flare prediction, and individualized treatment selection remain critical unmet needs. Recent advances in multimodal biomarkers—including serological and inflammatory markers, quantitative imaging (ultrasound/MRI), -omics signatures (e.g., interferon- and B-cell–related programs), and digital phenotypes f...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5c7850ed-fbc5-5c20-b599-e32678f4d8a9
- DOI
- 10.20944/preprints202510.0839.v1
